Navigation Links
British Hospitals Face Financial Crisis

Several hospitals in Britain's National Health Service (NHS) is facing a severe financial crunch, thereby resulting in job losses and changes// in work rules as well, which has deeply affected the employment prospects of Indian doctors.

The financial crunch further lessens the prospects of thousands of Indian doctors currently seeking employment in Britain. Almost every day, several hospitals announce job cuts to meet budget deficits. In recent weeks, the overall job losses in the NHS are said to be nearly 7,000 in 22 trusts and hospitals in different parts of the country.

New work rules have compounded the situation for them as now they can no longer work as part of "permit free training", and need work permits.

Britain's health authorities are faced with higher numbers of local medical graduates and many more from the expanded European Union who have the right to work in Britain. The situation makes it difficult for non-EU nationals - such as Indian doctors - to secure employment in the NHS.

An association of doctors of Indian origin has scheduled a demonstration outside the Department of Health here April 21 to protest the changes in work rules as applicable to Indian doctors.

Last week, York Hospitals NHS Trust decided to cut 200 jobs over the coming year as part of plans to save seven million pounds. Two days earlier the Worcestershire Acute Hospitals NHS Trust had announced that 720 jobs were to be axed as it tries to save 30 million pounds.

The University Hospital of North Staffordshire is cutting 1,000 jobs in the face of a 15.5 million pound debt, while Brighton and Sussex University Hospitals NHS Trust is also losing 325 posts as part of plans to save more than 10 million pounds over the next year.

The Royal Free Hospital in Hampstead, north London, is cutting about 480 jobs under plans to save 25 million pounds in the next year, and the Mid Cheshire Hospitals NHS Trust
'"/>




Page: 1 2

Related medicine news :

1. Designer baby for British couple
2. British Authorities Seize Spurious Drugs
3. Collaborations planned between British Organization and Indian health care industry
4. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
5. British Women Flies to India for Treatment of Breast Cancer
6. Sharp Increase In Morning-After Pill Sales Among British Women
7. British company developing ‘Safer Cigarettes
8. British man Recovered from HIV
9. British medical education suffers shortage of bodies
10. Relief For British MS Patients: Cannabis-Based Oral Spray
11. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
Post Your Comments:
Other Medicine News:Health News:Learning Disabilities May Presage Later Language Problems 2Health News:ACS is 'Best in KLAS' for Healthcare Consulting Services 2Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 2Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 3Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 4Health News:Patients with larger social networks may fare better after an operation 2Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 2Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 3Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 4Health News:Founding CEOS of SureScripts(R) and RxHub(R) Join Forces to Deliver Clinical Information Technology Services to Physician Practices 2Health News:Founding CEOS of SureScripts(R) and RxHub(R) Join Forces to Deliver Clinical Information Technology Services to Physician Practices 3
Breaking Medicine Technology:Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Negative Pressure Wound Devices Draw FDA Notice, Advice 2Hangovers May Be Tougher for Migraine Sufferers 59737 1Drugs for Irritable Bowel Might Increase Cancer Risk 59736 1Drugs for Irritable Bowel Might Increase Cancer Risk 59736 2Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 1Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 2Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 3